US Patent Issued to Oklahoma Medical Research Foundation on Aug. 18 for "Monoclonal antibody against human activated protein C and preparation and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,662, issued on Aug. 18, was assigned to Oklahoma Medical Research Foundation (Oklahoma City).

"Monoclonal antibody against human activated protein C and preparation and use thereof" was invented by Jun Xu (Shanghai), Lu Cheng (Shanghai), Jiawei Yi (Shanghai), Zhisong Xia (Shanghai) and Yeheng Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure belongs to the technical field of monoclonal antibodies, and relates to a monoclonal antibody against activated protein C (aPC). Amino acid sequences of a heavy chain and a light chain of the monoclonal antibody are shown in SEQ ID NOs: 5-26, and CDR sequences are shown in SEQ I...